Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Democratic Senate Poised To Approve More Generous COVID-19 Relief Bills, Biden Cabinet Chiefs

Executive Summary

Elections guaranteeing a Democratic Senate mean President-Elect Joe Biden can push for $2,000 COVID-19 relief checks and get his Cabinet choices.

You may also be interested in...



Radiologists, Other Out-Of-Network Providers See Partial Win In ‘Surprise Billing’ Law, Attorney Says

The US Congress’ choice to use an arbitration model will make a new “surprise billing” law easier to swallow, a corporate attorney tells Medtech Insight.

US Congress Roundup: Senators Reject COVID-19 Relief Plan; Lawmakers Fault Verma Promos

Upon US lawmakers’ return from an August recess, senators wrangle over an acceptable coronavirus relief package, while the House finalizes medtech bills and probes Medicare chief Seema Verma’s expenses.

Olympus, Pentax Working On Responses To Sen. Murray Duodenoscope Contamination Concerns

Two duodenoscope manufacturers – Olympus and Pentax – this week joined Fujifilm in saying they are aware of Senate HELP Committee ranking member Patty Murray’s concerns about recently released duodenoscope contamination levels and are working to complete postmarket surveillance studies of their devices, as required by the US FDA.

Topics

UsernamePublicRestriction

Register

LL035386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel